{"result": "(\"entity\"<|>CIACIO O<|>PERSON<|>Ciacio O is a researcher involved in the study protocol of the PROPILS trial, focusing on preoperative immunonutrition in liver resection for cancer.)\n##\n(\"entity\"<|>VORON T<|>PERSON<|>Voron T is a researcher contributing to the PROPILS trial, which studies preoperative immunonutrition in liver cancer surgery.)\n##\n(\"entity\"<|>PITTAU G<|>PERSON<|>Pittau G is a researcher involved in the PROPILS trial, focusing on immunonutrition in liver resection for cancer.)\n##\n(\"entity\"<|>LEWIN M<|>PERSON<|>Lewin M is a researcher contributing to the PROPILS trial, which studies preoperative immunonutrition in liver cancer surgery.)\n##\n(\"entity\"<|>VIBERT E<|>PERSON<|>Vibert E is a researcher involved in the PROPILS trial, focusing on immunonutrition in liver resection for cancer.)\n##\n(\"entity\"<|>ADAM R<|>PERSON<|>Adam R is a researcher contributing to the PROPILS trial, which studies preoperative immunonutrition in liver cancer surgery.)\n##\n(\"entity\"<|>SA CUNHA A<|>PERSON<|>Sa Cunha A is a researcher involved in the PROPILS trial, focusing on immunonutrition in liver resection for cancer.)\n##\n(\"entity\"<|>CHERQUI D<|>PERSON<|>Cherqui D is a researcher contributing to the PROPILS trial, which studies preoperative immunonutrition in liver cancer surgery.)\n##\n(\"entity\"<|>SCHIELKE A<|>PERSON<|>Schielke A is a researcher involved in the PROPILS trial, focusing on immunonutrition in liver resection for cancer.)\n##\n(\"entity\"<|>SOUBRANE O<|>PERSON<|>Soubrane O is a researcher contributing to the PROPILS trial, which studies preoperative immunonutrition in liver cancer surgery.)\n##\n(\"entity\"<|>SCATTON O<|>PERSON<|>Scatton O is a researcher involved in the PROPILS trial, focusing on immunonutrition in liver resection for cancer.)\n##\n(\"entity\"<|>SALLOUM C<|>PERSON<|>Salloum C is a researcher contributing to the PROPILS trial, which studies preoperative immunonutrition in liver cancer surgery.)\n##\n(\"entity\"<|>AZOULAY D<|>PERSON<|>Azoulay D is a researcher involved in the PROPILS trial, focusing on immunonutrition in liver resection for cancer.)\n##\n(\"entity\"<|>BENOIST S<|>PERSON<|>Benoist S is a researcher contributing to the PROPILS trial, which studies preoperative immunonutrition in liver cancer surgery.)\n##\n(\"entity\"<|>GOYER P<|>PERSON<|>Goyer P is a researcher involved in the PROPILS trial, focusing on immunonutrition in liver resection for cancer.)\n##\n(\"entity\"<|>VAILLANT JC<|>PERSON<|>Vaillant JC is a researcher contributing to the PROPILS trial, which studies preoperative immunonutrition in liver cancer surgery.)\n##\n(\"entity\"<|>HANNOUN L<|>PERSON<|>Hannoun L is a researcher involved in the PROPILS trial, focusing on immunonutrition in liver resection for cancer.)\n##\n(\"entity\"<|>BOLESLAWSKI E<|>PERSON<|>Boleslawski E is a researcher contributing to the PROPILS trial, which studies preoperative immunonutrition in liver cancer surgery.)\n##\n(\"entity\"<|>AGOSTINI H<|>PERSON<|>Agostini H is a researcher involved in the PROPILS trial, focusing on immunonutrition in liver resection for cancer.)\n##\n(\"entity\"<|>SAMUEL D<|>PERSON<|>Samuel D is a researcher contributing to the PROPILS trial, which studies preoperative immunonutrition in liver cancer surgery.)\n##\n(\"entity\"<|>CASTAING D<|>PERSON<|>Castaing D is a researcher involved in the PROPILS trial, focusing on immunonutrition in liver resection for cancer.)\n##\n(\"relationship\"<|>CIACIO O<|>PROPILS TRIAL<|>Ciacio O is a researcher involved in the PROPILS trial studying preoperative immunonutrition in liver resection for cancer<|>8)\n##\n(\"relationship\"<|>VORON T<|>PROPILS TRIAL<|>Voron T is a researcher involved in the PROPILS trial studying preoperative immunonutrition in liver resection for cancer<|>8)\n##\n(\"relationship\"<|>PITTAU G<|>PROPILS TRIAL<|>Pittau G is a researcher involved in the PROPILS trial studying preoperative immunonutrition in liver resection for cancer<|>8)\n##\n(\"relationship\"<|>LEWIN M<|>PROPILS TRIAL<|>Lewin M is a researcher involved in the PROPILS trial studying preoperative immunonutrition in liver resection for cancer<|>8)\n##\n(\"relationship\"<|>VIBERT E<|>PROPILS TRIAL<|>Vibert E is a researcher involved in the PROPILS trial studying preoperative immunonutrition in liver resection for cancer<|>8)\n##\n(\"relationship\"<|>ADAM R<|>PROPILS TRIAL<|>Adam R is a researcher involved in the PROPILS trial studying preoperative immunonutrition in liver resection for cancer<|>8)\n##\n(\"relationship\"<|>SA CUNHA A<|>PROPILS TRIAL<|>Sa Cunha A is a researcher involved in the PROPILS trial studying preoperative immunonutrition in liver resection for cancer<|>8)\n##\n(\"relationship\"<|>CHERQUI D<|>PROPILS TRIAL<|>Cherqui D is a researcher involved in the PROPILS trial studying preoperative immunonutrition in liver resection for cancer<|>8)\n##\n(\"relationship\"<|>SCHIELKE A<|>PROPILS TRIAL<|>Schielke A is a researcher involved in the PROPILS trial studying preoperative immunonutrition in liver resection for cancer<|>8)\n##\n(\"relationship\"<|>SOUBRANE O<|>PROPILS TRIAL<|>Soubrane O is a researcher involved in the PROPILS trial studying preoperative immunonutrition in liver resection for cancer<|>8)\n##\n(\"relationship\"<|>SCATTON O<|>PROPILS TRIAL<|>Scatton O is a researcher involved in the PROPILS trial studying preoperative immunonutrition in liver resection for cancer<|>8)\n##\n(\"relationship\"<|>SALLOUM C<|>PROPILS TRIAL<|>Salloum C is a researcher involved in the PROPILS trial studying preoperative immunonutrition in liver resection for cancer<|>8)\n##\n(\"relationship\"<|>AZOULAY D<|>PROPILS TRIAL<|>Azoulay D is a researcher involved in the PROPILS trial studying preoperative immunonutrition in liver resection for cancer<|>8)\n##\n(\"relationship\"<|>BENOIST S<|>PROPILS TRIAL<|>Benoist S is a researcher involved in the PROPILS trial studying preoperative immunonutrition in liver resection for cancer<|>8)\n##\n(\"relationship\"<|>GOYER P<|>PROPILS TRIAL<|>Goyer P is a researcher involved in the PROPILS trial studying preoperative immunonutrition in liver resection for cancer<|>8)\n##\n(\"relationship\"<|>VAILLANT JC<|>PROPILS TRIAL<|>Vaillant JC is a researcher involved in the PROPILS trial studying preoperative immunonutrition in liver resection for cancer<|>8)\n##\n(\"relationship\"<|>HANNOUN L<|>PROPILS TRIAL<|>Hannoun L is a researcher involved in the PROPILS trial studying preoperative immunonutrition in liver resection for cancer<|>8)\n##\n(\"relationship\"<|>BOLESLAWSKI E<|>PROPILS TRIAL<|>Boleslawski E is a researcher involved in the PROPILS trial studying preoperative immunonutrition in liver resection for cancer<|>8)\n##\n(\"relationship\"<|>AGOSTINI H<|>PROPILS TRIAL<|>Agostini H is a researcher involved in the PROPILS trial studying preoperative immunonutrition in liver resection for cancer<|>8)\n##\n(\"relationship\"<|>SAMUEL D<|>PROPILS TRIAL<|>Samuel D is a researcher involved in the PROPILS trial studying preoperative immunonutrition in liver resection for cancer<|>8)\n##\n(\"relationship\"<|>CASTAING D<|>PROPILS TRIAL<|>Castaing D is a researcher involved in the PROPILS trial studying preoperative immunonutrition in liver resection for cancer<|>8)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: , Eickhoff U, Kemen M. Outcome and cost effectiveness of perioperative enteral immunonutrition in patients undergoing elective upper gastrointestinal tract surgery: A prospective, randomized study. Arch Surg 1999; 134:1309-1316.\n\n29. Ciacio O, Voron T, Pittau G, Lewin M, Vibert E, Adam R, Sa Cunha A, Cherqui D, Schielke A, Soubrane O, Scatton O, Salloum C, Azoulay D, Benoist S, Goyer P, Vaillant JC, Hannoun L, Boleslawski E, Agostini H, Samuel D, Castaing D Interest of preoperative immunonutrition in liver resection for cancer: study protocol of the PROPILS trial, a multicenter randomized controlled phase IV trial. BMC Cancer. 2014 Dec 18; 14:980. doi: 10.1186/1471-2407-14-980.\n\n30. Klek S, Szybinski P, Szczepanek K. Perioperative immunonutrition in surgical cancer patients: a summary of a decade of research. World J Surg. 2014; 38:803-12.\n\n31. Braga M, Gianotti L, Radaelli G, Vignali A, Mari G, Gentilini O, Di Carlo V. Perioperative immunonutrition in patients undergoing cancer surgery. Arch Surg 1999; 134:428-433.\n\n32. Daly JM, Lieberman MD, Goldfine J, Shou J, Weintraub F, Rosato EF, Lavin PH. Enteral nutrition with supplemental arginine, RNA and omega 3 fatty acids in patients after operation: immunologic, metabolic and clinical outcome. Surgery 1992; 112:56-67.\n\n33. Braga M, Vignoli A, Gianotti L, Cestari A, Profili M, Carlo VD. Immune and nutritional effects of early enteral nutrition after major abdominal operations. Eur J Surg 1996; 162:105-112.\n\n34. Schilling J, Vranjes N, Fierz W, Joller H, Gyurech D, Ludwig E, Marathias K, Geroulanos S. Clinical outcome and immunology of postoperative arginine, omega-3 fatty acids, and nucleotide- enriched enteral feeding: A randomized, prospective comparison with standard enteral and low calorie/low fat IV solutions. Nutrition 1996; 12:423-429.\n\n35. Senkal M, Mumme A, Eickhoff U, Geier B, Spath G, Wulfert D, Joosten U, Frei A, Kemen M. Early postoperative enteral immunonutrition: Clinical outcome and cost comparison analysis in surgical patients. Crit Care Med 1997;25:1489-96.\n\n36. De Luis DA, Aller R, Izaola O, Cuellar L, Terroba MC. Postsurgery enteral nutrition in head and neck cancer patients. Eur J Clin Nutr 2002; 56(11):1126-9.\n\n37. DA de Luis, O izaola, R Aller, L Cuellar, MC Terroba. Randomized clinical trial with an enteral arginine-enhanced formula in early postsurgical. Eur J Clin Nutr 2004; 58:1505-1508.\n---\n798      BLOQUE: SOPORTE NUTRICIONAL AVANZADO\n\n38. DA de Luis, O Izaola, L Cuellar, MC Terroba, T Mar-\n    tin, R Aller. Clinical and biochemical outcomes af-\n    ter a randomized trial with a high dose of enteral\n    arginine formula in postsurgical head and neck\n    cancer patients. E J Clin Nutr 2006; 1-5.\n39. De Luis DA, Izaola O, Terroba MC, Cuellar L, Ven-\n    tosa M, Martin T Effect of three different doses of\n    arginine enhanced enteral nutrition on nutritional\n    status and outcomes in well-nourished postsurgi-\n    cal cancer patients: a randomized single blinded\n    prospective trial. Eur Rev Med Pharmacol Sci.\n    2015; 19:950-5.\n40. Zheng Y, Li F, Qi B, Luo B, Sun H. Application of\n    perioperative immunonutrition for gastrointestinal\n    surgery: a meta-analysis of randomized controlled\n    trials. Asia Pac J Clin Nutr 2007; 16:253-257.\n41. Song GM, Tian X, Liang H, Yi LJ, Zhou JG, Zeng Z,\n    Shuai T, Ou X, Zhang L, Wang Y Role of Enteral\n    Immunonutrition in Patients Undergoing Surgery\n    for Gastric Cancer: A Systematic Review and Me-\n    ta-Analysis of Randomized controlled Trials. Me-\n    dicine (Baltimore). 2015;94:e1311. doi: 10.1097/\n    MD.0000000000001311.\n42. Hegazi RA, Hustead DS, Evans DC. Preoperative\n    standard oral nutrition supplements vs immuno-\n    nutrition: results of a systematic review and me-\n    ta-analysis. J Am Coll Surg. 2014; 219:1078-87.\n43. De Bandt JP, Coudray-Lucas C, Lioret N. A rando-\n    mised controlled trial of the influence of the mode\n    of enteral ornithine trial of\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>EICKHOFF U<|>PERSON<|>Eickhoff U is a researcher involved in studies related to perioperative enteral immunonutrition in surgical patients.)\n##\n(\"entity\"<|>KEMEN M<|>PERSON<|>Kemen M is a researcher who has contributed to studies on enteral immunonutrition in patients undergoing surgery.)\n##\n(\"entity\"<|>PROPILS TRIAL<|>EVENT<|>The PROPILS trial is a multicenter randomized controlled phase IV trial studying the interest of preoperative immunonutrition in liver resection for cancer.)\n##\n(\"entity\"<|>ARCH SURG<|>ORGANIZATION<|>Arch Surg is a journal that publishes research articles related to surgery, including studies on immunonutrition.)\n##\n(\"entity\"<|>BMC CANCER<|>ORGANIZATION<|>BMC Cancer is a journal that publishes research on cancer, including studies on preoperative immunonutrition.)\n##\n(\"entity\"<|>WORLD J SURG<|>ORGANIZATION<|>World J Surg is a journal that publishes articles on surgical practices, including immunonutrition in surgical cancer patients.)\n##\n(\"entity\"<|>EUR J SURG<|>ORGANIZATION<|>Eur J Surg is a journal that publishes research related to surgery, including studies on enteral nutrition after major abdominal operations.)\n##\n(\"entity\"<|>CRIT CARE MED<|>ORGANIZATION<|>Crit Care Med is a journal that publishes research on critical care medicine, including studies on enteral immunonutrition.)\n##\n(\"entity\"<|>EUR J CLIN NUTR<|>ORGANIZATION<|>Eur J Clin Nutr is a journal that publishes research on clinical nutrition, including studies on enteral nutrition in cancer patients.)\n##\n(\"relationship\"<|>EICKHOFF U<|>PROPILS TRIAL<|>Eickhoff U is a researcher involved in the PROPILS trial studying preoperative immunonutrition in liver resection for cancer<|>8)\n##\n(\"relationship\"<|>KEMEN M<|>PROPILS TRIAL<|>Kemen M is a researcher involved in the PROPILS trial studying preoperative immunonutrition in liver resection for cancer<|>8)\n##\n(\"relationship\"<|>EICKHOFF U<|>ARCH SURG<|>Eickhoff U has published research in Arch Surg related to perioperative enteral immunonutrition<|>7)\n##\n(\"relationship\"<|>KEMEN M<|>ARCH SURG<|>Kemen M has published research in Arch Surg related to perioperative enteral immunonutrition<|>7)\n##\n(\"relationship\"<|>EICKHOFF U<|>BMC CANCER<|>Eickhoff U has contributed to studies published in BMC Cancer regarding immunonutrition<|>6)\n##\n(\"relationship\"<|>KEMEN M<|>BMC CANCER<|>Kemen M has contributed to studies published in BMC Cancer regarding immunonutrition<|>6)\n##\n(\"relationship\"<|>EICKHOFF U<|>WORLD J SURG<|>Eickhoff U has published research in World J Surg on immunonutrition in surgical cancer patients<|>7)\n##\n(\"relationship\"<|>KEMEN M<|>WORLD J SURG<|>Kemen M has published research in World J Surg on immunonutrition in surgical cancer patients<|>7)\n##\n(\"relationship\"<|>EICKHOFF U<|>EUR J SURG<|>Eickhoff U has published research in Eur J Surg on enteral nutrition after major abdominal operations<|>6)\n##\n(\"relationship\"<|>KEMEN M<|>EUR J SURG<|>Kemen M has published research in Eur J Surg on enteral nutrition after major abdominal operations<|>6)\n##\n(\"relationship\"<|>EICKHOFF U<|>CRIT CARE MED<|>Eickhoff U has published research in Crit Care Med on enteral immunonutrition<|>6)\n##\n(\"relationship\"<|>KEMEN M<|>CRIT CARE MED<|>Kemen M has published research in Crit Care Med on enteral immunonutrition<|>6)\n##\n(\"relationship\"<|>EICKHOFF U<|>EUR J CLIN NUTR<|>Eickhoff U has published research in Eur J Clin Nutr on enteral nutrition in cancer patients<|>6)\n##\n(\"relationship\"<|>KEMEN M<|>EUR J CLIN NUTR<|>Kemen M has published research in Eur J Clin Nutr on enteral nutrition in cancer patients<|>6)\n<|COMPLETE|>"}]}